These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 28024169)

  • 21. Method comparison of the Ortho Vitros Fusion 5,1 chemistry analyzer and the Roche COBAS Integra 400 for urine drug screen testing in the emergency department.
    Johnson-Davis KL; Thompson CD; Clark CJ; McMillin GA; Lehman CM
    J Anal Toxicol; 2012 Jun; 36(5):345-8. PubMed ID: 22582270
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rapid analysis of drugs of abuse and their metabolites in human urine using dilute and shoot liquid chromatography-tandem mass spectrometry.
    Kong TY; Kim JH; Kim JY; In MK; Choi KH; Kim HS; Lee HS
    Arch Pharm Res; 2017 Feb; 40(2):180-196. PubMed ID: 27988881
    [TBL] [Abstract][Full Text] [Related]  

  • 23. KIMS, CEDIA, and HS-CEDIA immunoassays are inadequately sensitive for detection of benzodiazepines in urine from patients treated for chronic pain.
    Darragh A; Snyder ML; Ptolemy AS; Melanson S
    Pain Physician; 2014; 17(4):359-66. PubMed ID: 25054395
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevalence of drugs of abuse found in testing of illicit drug seizures and urinalysis of selected population in Hong Kong.
    Cheng WC; Dao KL
    Forensic Sci Int; 2019 Jun; 299():6-16. PubMed ID: 30954006
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High levels of agreement between clinic-based ethyl glucuronide (EtG) immunoassays and laboratory-based mass spectrometry.
    Leickly E; McDonell MG; Vilardaga R; Angelo FA; Lowe JM; McPherson S; Srebnik D; Roll JM; Ries RK
    Am J Drug Alcohol Abuse; 2015 May; 41(3):246-50. PubMed ID: 25695340
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Optimization and validation of CEDIA drugs of abuse immunoassay tests in serum on Hitachi 912.
    Kirschbaum KM; Musshoff F; Schmithausen R; Stockhausen S; Madea B
    Forensic Sci Int; 2011 Oct; 212(1-3):252-5. PubMed ID: 21775079
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The utility of immunoassays for urine drug testing.
    Melanson SE
    Clin Lab Med; 2012 Sep; 32(3):429-47. PubMed ID: 22939301
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Precision and comparability of Abuscreen OnLine assays for drugs of abuse screening in urine on Hitachi 917 with other immunochemical tests and with GC/MS.
    Boettcher M; Haenseler E; Hoke C; Nichols J; Raab D; Domke I
    Clin Lab; 2000; 46(1-2):49-52. PubMed ID: 10745981
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Biomarkers of alcohol abuse in racehorses by liquid chromatography/tandem mass spectrometry.
    You Y; Uboh CE; Soma LR; Guan F; Li X; Rudy JA; Chen J
    Rapid Commun Mass Spectrom; 2007; 21(23):3785-94. PubMed ID: 17973234
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Utility of coloured hair for the detection of drugs and alcohol.
    Agius R
    Drug Test Anal; 2014 Jun; 6 Suppl 1():110-9. PubMed ID: 24817056
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Validation of LUCIO-Direct-ELISA kits for the detection of drugs of abuse in urine: application to the new German driving licence re-granting guidelines.
    Agius R; Nadulski T; Moore C
    Forensic Sci Int; 2012 Feb; 215(1-3):38-45. PubMed ID: 22075096
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Modification of screening immunoassays to detect sub-threshold concentrations of cocaine, cannabinoids, and opiates in urine: use for detecting maternal and neonatal drug exposures.
    Hattab EM; Goldberger BA; Johannsen LM; Kindland PW; Ticino F; Chronister CW; Bertholf RL
    Ann Clin Lab Sci; 2000 Jan; 30(1):85-91. PubMed ID: 10678589
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Analysis of anonymous pooled urine from portable urinals in central London confirms the significant use of novel psychoactive substances.
    Archer JR; Dargan PI; Hudson S; Wood DM
    QJM; 2013 Feb; 106(2):147-52. PubMed ID: 23178933
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Use of LC-HRMS in full scan-XIC mode for multi-analyte urine drug testing - a step towards a 'black-box' solution?
    Stephanson NN; Signell P; Helander A; Beck O
    J Mass Spectrom; 2017 Aug; 52(8):497-506. PubMed ID: 28493314
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Modification and evaluation of Abuscreen OnLine assays for drug metabolites in urine performed on a COBAS FARA II in comparison with EMIT d.a.u. Cannabinoid 20.
    Hailer M; Glienke Y; Schwab IM; von Meyer L
    J Anal Toxicol; 1995; 19(2):99-103. PubMed ID: 7769796
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Simultaneous detection of 19 drugs of abuse on dried urine spot by liquid chromatography-tandem mass spectrometry.
    Lee Y; Lai KKY; Sadrzadeh SMH
    Clin Biochem; 2013 Aug; 46(12):1118-1124. PubMed ID: 23583348
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Screening and confirmation of 62 drugs of abuse and metabolites in urine by ultra-high-performance liquid chromatography-quadrupole time-of-flight mass spectrometry.
    Tsai IL; Weng TI; Tseng YJ; Tan HK; Sun HJ; Kuo CH
    J Anal Toxicol; 2013; 37(9):642-51. PubMed ID: 24084874
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A fully validated high-performance liquid chromatography-tandem mass spectrometry method for the determination of ethyl glucuronide in hair for the proof of strict alcohol abstinence.
    Albermann ME; Musshoff F; Madea B
    Anal Bioanal Chem; 2010 Apr; 396(7):2441-7. PubMed ID: 20130844
    [TBL] [Abstract][Full Text] [Related]  

  • 39. False-positive ethyl glucuronide immunoassay screening associated with chloral hydrate medication as confirmed by LC-MS/MS and self-medication.
    Arndt T; Gierten B; Güssregen B; Werle A; Grüner J
    Forensic Sci Int; 2009 Jan; 184(1-3):e27-9. PubMed ID: 19084359
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Trend analysis of anonymised pooled urine from portable street urinals in central London identifies variation in the use of novel psychoactive substances.
    Archer JR; Dargan PI; Lee HM; Hudson S; Wood DM
    Clin Toxicol (Phila); 2014 Mar; 52(3):160-5. PubMed ID: 24506433
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.